| A - Alimentary Tract and Metabolism | | |
|
| A16 - Other Alimentary Tract and Metabolism Products | | |
|
| A16A - Other Alimentary Tract and Metabolism Products | This group comprises all products acting on the alimentary tract and metabolism which cannot be classified in the preceding groups. V03 - All other therapeutic products, should also be considered.
Nutrients are classified in V06 - General nutrients.
|
|
| A16AX - Various Alimentary Tract and Metabolism Products | Thioctic acid is classified in this group.
This group includes gene therapy products resulting in the expression of specific proteins.
| The DDD for zinc acetate is expressed as the amount of zinc (Zn).
The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.
The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.
The DDD for miglustat is based on the treatment of Gauchers disease.
|
|
| A16AX03 - Sodium Phenylbutyrate | |
|
